From 1 July 2024, the Government will fund a blood test called the āNT-proBNPā test for Australians living with Pulmonary Arterial Hypertension (PAH).
This test can be done as part of a regular risk assessment to check if a personās #PAH has progressed.
ā”ļøsclerodermaaustralia.com.au/ā¦
Congratulations to A/Prof Hilmy Ismail & Prof Bernhard Riedel who have been awarded a Medical Research Future Fund (MRFF) grant worth nearly $3 million to investigate the use of AI to predict and reduce complications after surgery. Read more:
petermac.org/about-us/news-aā¦
"If this treatment option is effective, we would hope that we would be able to prolong the lives of individuals who have this type of breast cancer." - Study Chair, Professor Sarah-Jane Dawson.
breastcancertrials.org.au/cuā¦
Based on our survey results, it's evident that
scleroderma profoundly impacts those living with the
condition.
To improve quality of life for these individuals, further
research is essential.
#scleroderma#sclerodermaawareness
Academic misconduct has once again made headlines, highlighting the need for better research oversight. Prof @SimonGandevia, founder of Retractions Australia and Deputy Director of NeuRA, discussed this on @RNBreakfast with @PatsKarvelas. Full interview: abc.net.au/listen/programs/rā¦
Ever wondered how new cancer treatments become available and equitable for all Australians?
Here's how you can get access to these new treatments and get involved in the process > buff.ly/3X1ctHS
June marks Bowel Cancer Awareness Month in Australia. šā¤ļø
Let's raise awareness and support those affected. Visit @bowelcanceraustralia or bowelcanceraustralia.org to learn how you can help.
Happy World Environment Day! š
At Breast Cancer Trials we believe in creating a better world for future generations. Whether itās reducing paper, investing ethically or using an ethical energy supplier, at Breast Cancer Trials weāre doing our best to help fight climate change.
Amazing to have not one but two Peter Mac researchers (@LoiSher, @SandhuShahneen) featured in @theheraldsun with results from trials they were PIs on reporting very positive results for immunotherapy ahead of surgery in breast and lung cancer. Reported at #ASCO24 and @NEJM
@theheraldsun A drug combination given to breast cancer and melanoma patients before surgery may dramatically improve their outcomes and rewrite the treatment rule book, a world-first study has revealed.
@PeterMacCCheraldsun.com.au/news/victorā¦